Liver Cancer News
Liver Cancer Incidence is on the Rise in the United States (May 25, 2010)From 2001 to 2006, the incidence of hepatocellular carcinoma (HCC) increased significantly with an average increase of 3.5% annually. This analysis was recently reported in the Centers for Disease Control and Prevention’s (CDC) Morbidity and Mortality... Continue Reading
Combination Chemotherapy Improves Survival with Biliary Tract Cancer (May 17, 2010)According to the results of a Phase III clinical trial, treatment of locally advanced or metastatic biliary tract cancer with a combination of Gemzar® (gemcitabine) and cisplatin results in better survival and a lower risk of cancer progression than... Continue Reading
Liver Cancer Often Linked to Diabetes (May 4, 2010)Diabetes increases the risk of hepatocellular carcinoma (HCC) and may account for a greater number of HCC cases in the United States than any other single HCC risk factor. These results were presented at the 101st annual meeting of the American Association... Continue Reading
Women with Hypothyroidism at Increased Risk of Liver Cancer (June 22, 2009)Women with Hypothyroidism at Increased Risk of Liver Cancer Long-term hypothyroidism in women significantly increases the risk of developing hepatocellular carcinoma (liver cancer), according to the results of a study published in Hepatology.[1] The liver... Continue Reading
Incidence of Liver Cancer on the Rise (April 8, 2009)The incidence of liver cancer in the United States tripled between 1975 and 2005, but survival rates are improving, according to the results of a study published in the Journal of Clinical Oncology. The liver is the largest organ in the body and is responsible... Continue Reading
Latest Liver Cancer News By Stage
Hepatocellular Carcinoma Liver Cancer
Sutent® Not Effective for Advanced Liver Cancer (July 10, 2009)
In a Phase II clinical trial, patients with inoperable, advanced hepatocellular (liver) cancer did not benefit from treatment with the targeted therapy Sutent® (sunitinib). The results of this study were published in Lancet Oncology. Hepatocellular carcinoma... Continue Reading
Women with Hypothyroidism at Increased Risk of Liver Cancer (June 22, 2009)Women with Hypothyroidism at Increased Risk of Liver Cancer Long-term hypothyroidism in women significantly increases the risk of developing hepatocellular carcinoma (liver cancer), according to the results of a study published in Hepatology.[1] The liver... Continue Reading
Genetic Characteristics of Hepatitis B Associated with Risk of Liver Cancer (March 8, 2009)Genetic Characteristics of Hepatitis B Associated with Risk of Liver Cancer Different genetic characteristics of the hepatitis B virus (HBV) are associated with varying risks of developing hepatocellular carcinoma (HCC), the most common form of liver... Continue Reading
Nexavar® Improves Survival in Advanced Liver Cancer (March 8, 2009)Nexavar® Improves Survival in Advanced Liver Cancer The targeted agent Nexavar (sorafenib) is associated with improved survival and doubling of the time to cancer progression for patients with advanced liver cancer. These results were recently published... Continue Reading
Liver Cancer Screening in Patients with Chronic Hepatitis B and C Improves Survival (March 8, 2009)Liver Cancer Screening in Patients with Chronic Hepatitis B and C Improves Survival Researchers in Hong Kong have reported that screening patients with chronic hepatitis for liver cancer improves liver cancer survival rates and may improve chances for... Continue Reading
More Hepatocellular Carcinoma Liver CancerRecurrent Liver Cancer
Sorry, there are no articles available for this cancer stage.
More Recurrent Liver CancerScreening/Prevention Liver Cancer
Liver Cancer Incidence is on the Rise in the United States (May 25, 2010)
From 2001 to 2006, the incidence of hepatocellular carcinoma (HCC) increased significantly with an average increase of 3.5% annually. This analysis was recently reported in the Centers for Disease Control and Prevention’s (CDC) Morbidity and Mortality... Continue Reading
Liver Cancer Often Linked to Diabetes (May 4, 2010)Diabetes increases the risk of hepatocellular carcinoma (HCC) and may account for a greater number of HCC cases in the United States than any other single HCC risk factor. These results were presented at the 101st annual meeting of the American Association... Continue Reading
Women with Hypothyroidism at Increased Risk of Liver Cancer (June 22, 2009)Women with Hypothyroidism at Increased Risk of Liver Cancer Long-term hypothyroidism in women significantly increases the risk of developing hepatocellular carcinoma (liver cancer), according to the results of a study published in Hepatology.[1] The liver... Continue Reading
Genetic Characteristics of Hepatitis B Associated with Risk of Liver Cancer (March 8, 2009)Genetic Characteristics of Hepatitis B Associated with Risk of Liver Cancer Different genetic characteristics of the hepatitis B virus (HBV) are associated with varying risks of developing hepatocellular carcinoma (HCC), the most common form of liver... Continue Reading
Liver Cancer Screening in Patients with Chronic Hepatitis B and C Improves Survival (March 8, 2009)Liver Cancer Screening in Patients with Chronic Hepatitis B and C Improves Survival Researchers in Hong Kong have reported that screening patients with chronic hepatitis for liver cancer improves liver cancer survival rates and may improve chances for... Continue Reading
More Screening/Prevention Liver CancerStage IV Liver Cancer
Combination Chemotherapy Improves Survival with Biliary Tract Cancer (May 17, 2010)
According to the results of a Phase III clinical trial, treatment of locally advanced or metastatic biliary tract cancer with a combination of Gemzar® (gemcitabine) and cisplatin results in better survival and a lower risk of cancer progression than... Continue Reading
Sutent® Not Effective for Advanced Liver Cancer (July 10, 2009)In a Phase II clinical trial, patients with inoperable, advanced hepatocellular (liver) cancer did not benefit from treatment with the targeted therapy Sutent® (sunitinib). The results of this study were published in Lancet Oncology. Hepatocellular carcinoma... Continue Reading
Avastin® plus Tarceva® Shows Promise in Advanced Hepatocellular Carcinoma (March 8, 2009)Avastin® plus Tarceva® Shows Promise in Advanced Hepatocellular Carcinoma According to the results of a Phase II clinical trial, the combination of two targeted therapies-Avastin® (bevacizumab) and Tarceva® (erlotinib)-has anticancer activity in patients... Continue Reading
Nexavar® Effective for Hepatocellular Carcinoma in Asians (March 8, 2009)Nexavar® Effective for Hepatocellular Carcinoma in Asians Researchers from 23 medical centers in Asia have reported that Nexavar® (sorafenib) is effective in patients with advanced hepatocellular carcinoma (liver cancer). The results of this study were... Continue Reading
More Stage IV Liver CancerStages I-III Liver Cancer
Combination Chemotherapy Improves Survival with Biliary Tract Cancer (May 17, 2010)
According to the results of a Phase III clinical trial, treatment of locally advanced or metastatic biliary tract cancer with a combination of Gemzar® (gemcitabine) and cisplatin results in better survival and a lower risk of cancer progression than... Continue Reading
Sutent® Not Effective for Advanced Liver Cancer (July 10, 2009)In a Phase II clinical trial, patients with inoperable, advanced hepatocellular (liver) cancer did not benefit from treatment with the targeted therapy Sutent® (sunitinib). The results of this study were published in Lancet Oncology. Hepatocellular carcinoma... Continue Reading
Differences in IMRT Radiation Doses May Complicate Study Results in Liver Cancer (March 8, 2009)Differences in IMRT Radiation Doses May Complicate Study Results in Liver Cancer Differences between the prescribed dose of radiation in intensity modulated radiation therapy (IMRT) and the dose that’s actually delivered may make comparison studies... Continue Reading
Avastin® plus Tarceva® Shows Promise in Advanced Hepatocellular Carcinoma (March 8, 2009)Avastin® plus Tarceva® Shows Promise in Advanced Hepatocellular Carcinoma According to the results of a Phase II clinical trial, the combination of two targeted therapies-Avastin® (bevacizumab) and Tarceva® (erlotinib)-has anticancer activity in patients... Continue Reading
Nexavar® Effective for Hepatocellular Carcinoma in Asians (March 8, 2009)Nexavar® Effective for Hepatocellular Carcinoma in Asians Researchers from 23 medical centers in Asia have reported that Nexavar® (sorafenib) is effective in patients with advanced hepatocellular carcinoma (liver cancer). The results of this study were... Continue Reading
More Stages I-III Liver Cancer